Magnetic resonance spectroscopy for the diagnosis of suspected breast malignancies
Sullivan T, Merlin T
Record ID 32006001410
English
Authors' results and conclusions:
Proton magnetic resonance spectroscopy (MRS) is a complementary technique to magnetic resonance imaging (MRI) capable of improving patient management by reducing the number of unnecessary biopsy referrals. Given appropriate infrastructure, the incorporation of MRS into a breast MRI examination could be achieved in less than 10 minutes. At present however, there is only limited evidence demonstrating the effectiveness of MRS for improving the diagnostic qualities of MRI breast examinations.
Authors' recommendations:
Although it is unclear how easily MRS could be incorporated into an MRI examination of the breast in Australia, the technology may offer benefits to a select group of patients. At present a Medical Services Advisory Committee (MSAC) report into the use of MRI for diagnosing breast cancer in high risk women is pending completion. It is recommended that MRS for breast cancer examination be monitored until the results of the MSAC assessment are finalised.
Details
Project Status:
Completed
Year Published:
2006
URL for published report:
Not Available
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Australia
MeSH Terms
- Female
- Magnetic Resonance Spectroscopy
- Breast Neoplasms
Contact
Organisation Name:
Adelaide Health Technology Assessment
Contact Address:
School of Public Health, Mail Drop 545, University of Adelaide, Adelaide SA 5005, AUSTRALIA, Tel: +61 8 8313 4617
Contact Name:
ahta@adelaide.edu.au
Contact Email:
ahta@adelaide.edu.au
Copyright:
Adelaide Health Technology Assessment (AHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.